WuHan Hvsen Biotechnology: Investor Relations Activity Schedule for May 6, 2024
WuHan Hvsen Biotechnology: CITIC Construction Investment Securities Co., Ltd.'s 2023 follow-up report on Wuhan Huisheng Biotechnology Co., Ltd.
WuHan Hvsen Biotechnology: CITIC Construction Investment Securities Co., Ltd. report on the 2023 continuous supervision and regular on-site inspection report of Wuhan Huisheng Biotechnology Co., Ltd.
WuHan Hvsen Biotechnology: Notice on re-signing the quadripartite supervisory agreement on fund-raising after changing the sponsoring agency
WuHan Hvsen Biotechnology: Investor Relations Activity Schedule for April 25, 2024
Huisheng Biotech: 2023 Independent Director Debriefing Report (Zeng Zhenling)
Huisheng Biotech: Announcement on holding the 2023 online performance briefing
Huisheng Biotech: Verification Opinions of CITIC Construction Investment Securities Co., Ltd. on the 2023 Internal Control Self-Assessment Report of Wuhan Huisheng Biotechnology Co., Ltd.
Huisheng Biotech: 2023 Supervisory Committee Work Report
Huisheng Biotech: 2023 Annual Audit Report
Huisheng Biotech: CITIC Construction Investment Securities Co., Ltd. special inspection report on the storage and use of funds raised by Wuhan Huisheng Biotechnology Co., Ltd. in 2023
Huisheng Biotech: 2023 Board Work Report
Huisheng Biotech: Special Verification Report on the 2023 Operating Income Deduction Statement of Wuhan Huisheng Biotechnology Co., Ltd.
Huisheng Biotech: 2023 Independent Director Debriefing Report (Xie Huobao)
Huisheng Biotech: CITIC Construction Investment Securities Co., Ltd.'s inspection opinions on Wuhan Huisheng Biotechnology Co., Ltd. and its subsidiaries applying for comprehensive credit lines from financial institutions in 2024 and having actual controllers provide guarantees and related transactions
Huisheng Biotech: Supervisory Board Resolutions Announced
Huisheng Biotech: Special Audit Report on the Summary Table of Non-operating Capital Occupation and Other Related Capital Transactions of Wuhan Huisheng Biotechnology Co., Ltd.
Huisheng Biotech: Announcement on the company and its subsidiaries applying for comprehensive credit lines from financial institutions in 2024 and providing guarantees and related transactions by the company's actual controller
Huisheng Biotech: Announcement on renewing the 2024 Audit Institution
Huisheng Biotech: Announcement of Board Resolutions
No Data